www.bracco.com
Home
Disclaimer
The List
Safety Information
Research summary
Screening Form
Product Testing
Ordering Books
Lectures
About Dr.Shellock
Priority E-mail

MRI Safety

www.bracco.com

Safety Information


The information on this page is limited by the terms of our disclaimer. Please Read!

Breast Tissue Expanders and Implants

Adjustable breast tissue expanders and mammary implants are utilized for breast reconstruction following mastectomy, for the correction of breast and chest-wall deformities and underdevelopment, for tissue defect procedures, and for cosmetic augmentation. These devices are typically equipped with either an integral injection site or a remote injection dome that is utilized to accept a needle for placement of saline for expansion of the prosthesis intra-operatively and/or postoperatively.


There are many different types of breast tissue expanders. For example, the Becker and the Siltex prostheses provide a choice of a standard injection dome or a micro-injection dome. The Radovan expander is indicated for temporary implantation only. The injection port for this device contains 316L stainless steel to guard against piercing the injection port by the needle used to fill the implant.


Notably, there are various breast tissue expanders that have magnetic ports to allow for a more accurate detection of the injection site. These devices are substantially attracted to the static magnetic fields of MR systems and, therefore, may be uncomfortable, injurious, or contraindicated for patients undergoing MR procedures. One such device is the Contour Profile Tissue Expander (Mentor, Santa Barbara, CA), which contains a magnetic injection dome and is considered to be unsafe for an MR examination.


Breast tissue expanders with magnetic ports produce relatively large artifacts on MR images and, as such, assessment of the breast using MR imaging is problematic. Importantly, there may be a situation during which a patient is referred for MR imaging for the determination of breast cancer or a breast implant rupture, such that the presence of the metallic artifact could obscure the precise location of the abnormality. In view of this possibility, it is recommended that a patient with a breast tissue expander that has a metallic component be identified prior to MRI so that the radiologist is aware of the potential problems related to the generation of artifacts as well as a possible injury.


McGhan Medical Breast Tissue Expanders and MRI Issues.

McGhan Medical Breast Tissue Expanders are intended for temporary subcutaneous implantation to develop surgical flaps and additional tissue coverage (Product Information, Style 133 Family of Breast Tissue Expanders with MAGNA-SITE Injection Sites, McGhan Medical/INAMED Aesthetics, Santa Barbara, CA). These breast tissue expanders are constructed from silicone elastomer and consist of an expansion envelope with a textured surface, and a MAGNA-SITE integrated injection site. The expanders are available in a wide range of styles and sizes to meet diverse surgical needs. Specific styles include: Style 133 FV with MAGNA-SITE injection site, Style 133 LV with MAGNA-SITE injection site, Style 133 MV with MAGNA-SITE injection site.
The MAGNA-SITE injection site and MAGNA-FINDER external locating device contain rare-earth, permanent magnets for an accurate injection system. When the MAGNA-FINDER is passed over the surface of the tissue being expanded, its rare-earth, permanent magnet indicates the location of the MAGNA-SITE injection site.


The Product Information document for the McGhan Medical Breast Tissue Expanders (Style 133 Family of Breast Tissue Expanders with MAGNA-SITE Injection Sites, McGhan Medical/INAMED Aesthetics, Santa Barbara, CA) states: “DO NOT use MAGNA-SITE expanders in patients who already have implanted devices that would be affected by a magnetic field (e.g., pacemakers, drug infusion devices, artificial sensing devices). DO NOT perform diagnostic testing with Magnetic Resonance Imaging (MRI) in patients with MAGNA-SITE expanders in place.”


Furthermore, in the Warnings section of the Product Information document, the following is indicated: “Diagnostic testing with Magnetic Resonance Imaging (MRI) is contraindicated in patients with MAGNA-SITE expanders in place. The MRI equipment could cause movement of the MAGNA-SITE breast tissue expander, and result in not only patient discomfort, but also expander displacement, requiring revision surgery. In addition, the MAGNA-SITE magnet could interfere with MRI detection capabilities.”


Therefore, MR procedures are deemed unsafe for patients with the McGhan Medical Breast Tissue Expanders, Style 133 Family of Breast Tissue Expanders with MAGNA-SITE Injection Sites (McGhan Medical/INAMED Aesthetics, Santa Barbara, CA).


Zegzula et al. presented a case of bilateral tissue expander infusion port dislodgment associated with an MRI examination. The report involved a 56-year-old woman that underwent bilateral mastectomy and immediate reconstruction with McGhan BIOSPAN tissue expanders. As noted, these implants contain the “MAGNA-SITE” components. Several weeks postoperatively the patient underwent MR imaging of her spine. Subsequently, the infusion ports could not be located with the finder magnet (used to re-fill the tissue expander). A chest radiograph was obtained that demonstrated bilateral dislodgment of the infusion ports. Surgical removal and replacement of the tissue expanders were required. This incident emphasizes that all patients undergoing tissue expansion with implants that contain magnetic ports should be thoroughly warned about the potential hazards of MR imaging.


In another incident involving a tissue expander, Duffy and May reported a case of a woman who developed a burning sensation at the site of the tissue expander during an MR procedure. The sensation resolved rapidly once the scan was discontinued. The implications of the symptoms for in this case are unclear. Nevertheless, a patient with a tissue expander that requires an MR procedure should be alerted to the possibility of localized symptoms in the region of the implant during scanning.


REFERENCES
Duffy FJ Jr, May JW Jr. Tissue expanders and magnetic resonance imaging: the “hot” breast implant. Ann Plast Surg 1995;5:647-9.


Fagan LL, Shellock FG, Brenner RJ, Rothman B. Ex vivo evaluation of ferromagnetism, heating, and artifacts of breast tissue expanders exposed to a 1.5-T MR system. J Magn Reson Imaging 1995;5:614-616.


Liang MD, Narayanan K, Kanal E. Magnetic ports in tissue expanders: a caution for MRI. Magn Reson Imaging 1989;7:541-542.


Product Information, Style 133 Family of Breast Tissue Expanders with Magna-Site Injection Sites, McGhan Medical/INAMED Aesthetics, Santa Barbara, CA.


Shellock FG, Kanal E. Magnetic Resonance: Bioeffects, Safety, and Patient Management. Second Edition, Lippincott-Raven Press, New York, 1996.


Zegzula HD, Lee WP. Infusion port dislodgment of bilateral breast tissue expanders after MRI. Ann Plast Surg 2001;46:46-8.


 
(c) 2009/2010 by Shellock R & D Services, Inc. and Frank G. Shellock, Ph.D. All Rights Reserved. All copyrights and pertinent trademarks are owned by Shellock R & D Services, Inc. and Frank G. Shellock, Ph.D. No part of the MRIsafety.com web site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, physical, electronic or otherwise, without the prior written permission of Shellock R & D Services, Inc. or Frank G. Shellock, Ph. D.

Request for permission to reproduce any information contained on the MRIsafety.com web site should be addressed to: frank.shellock@gte.net

Be sure to read our disclaimer.